Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat-dose inhaled GSK256066 for allergen-induced late asthmatic response in mild asthma
2005-005339-83Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK256066 in asthma, sponsored by GSK. Started Feb 2006; status: completed.
02
Drugs
GSK256066
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-005339-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005339-83.